Melguizo Alonso, Consolación Author
Production of a new monoclonal antibody recognizing alpha-actinin: analysis of the changes in subcellular expression in the developing chick heart.
- PRADOS, J
- MELGUIZO, C
- ARANEGA, AE
- FERNANDEZ, JE
- ALVAREZ, L
- ARANEGA, A
Cellular and Molecular Biology - 1/02/1993
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Modulation of contractile protein troponin-T in chick myocardial cells by catecholamines during development.
- VELEZ, C
- ARANEGA, AE
- FERNANDEZ, JE
- MELGUIZO, C
- ALVAREZ, L
- ARANEGA, A
Cellular and Molecular Biology - 1/12/1994
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Modulation of Ki-67 expression and morphological changes induced by GEF gene in MCF-7 human breast cancer cells
- Boulaiz, H
- Prados, J
- Marchal, JA
- Melguizo, C
- Concha, A
- Carrillo, E
- Velez, C
- Martinez, A
- Aranega, A
Cellular and Molecular Biology - 2/9/2005
- JCR Quartile: Q4 (2005)
- SJR Quartile: Q2
- JCR Impact Factor: 1.018 (2022)
- Category normalized Impact: 0.072 (2005)
- CiteScore: 2.5 (2020)
- SJR: 0.482 (2005
- SJR Categories: Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
Cancer gene therapy: Strategies and clinical trials
- Prados, J
- Melguizo, C
- Boulaiz, H
- Marchal, JA
- Aranega, A
Cellular and Molecular Biology - 2/9/2005
- JCR Quartile: Q4 (2005)
- SJR Quartile: Q2
- JCR Impact Factor: 1.018 (2022)
- Category normalized Impact: 0.069 (2005)
- CiteScore: 2.5 (2020)
- SJR: 0.482 (2005
- SJR Categories: Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.
- PRADOS, J
- MELGUIZO, C
- FERNANDEZ, JE
- ARANEGA, AE
- ALVAREZ, L
- ARANEGA, A
Cellular and Molecular Biology - 1/07/1993
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
ACTINOMYCIN-D CAUSES MULTIDRUG-RESISTANCE AND DIFFERENTIATION IN A HUMAN RHABDOMYOSARCOMA CELL-LINE
- MELGUIZO, C
- PRADOS, J
- FERNANDEZ, JE
- VELEZ, C
- ALVAREZ, L
- ARANEGA, A
CELLULAR AND MOLECULAR BIOLOGY - 1/03/1994
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation (vol 42, pg 1219, 1996)
- Aranega, A
- Marchal, JA
- Melguizo, C
- Prados, J
- Aranega, AE
- Velez, C
- Fernandez, JE
- Arena, N
- Alvarez, L
CELLULAR AND MOLECULAR BIOLOGY - 12/1997
Non-viral and viral vectors for gene therapy
- Boulaiz, H
- Marchal, JA
- Prados, J
- Melguizo, C
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 2/9/2005
- JCR Quartile: Q4 (2005)
- SJR Quartile: Q2
- JCR Impact Factor: 1.018 (2022)
- Category normalized Impact: 0.755 (2005)
- CiteScore: 2.5 (2020)
- SJR: 0.482 (2005
- SJR Categories: Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation.
- Aranega, A
- Marchal, JA
- Melguizo, C
- Prados, J
- Aranega, AE
- Velez, C
- Fernandez, JE
- Arena, N
- Alvarez, L
Cellular and molecular biology (Noisy-le-Grand, France) - 1/12/1996
- JCR Impact Factor: 1.27 (2022)
- Category normalized Impact: 0.075 (1996)
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
- Carrillo, E
- Marchal, JA
- Prados, J
- Melguizo, C
- Velez, C
- Arena, N
- Alvarez, L
- Serrano, S
- Aranega, A
Cellular and molecular biology (Noisy-le-Grand, France) - 1/12/1998
- JCR Quartile: Q3 (1998)
- JCR Impact Factor: 1.151 (2022)
- Category normalized Impact: 0.11 (1998)
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- JCR Impact Factor: 4.9 (2023)
- JCR 5-year Impact Factor: 5.5
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador